Phil Carroll and Kevin Hornsby are joined by Che Connon, Chief Executive of 3DBT and Geoff Baker, executive director of BSF Enterprise.  3D Bio-Tissues secured its first distribution agreement and three new customers for its patented City-Mix™ supplement. Although initial sales are modest, this achievement marks an important milestone for the company, demonstrating product quality.

3DBT has entered into direct sales agreements with two lab-grown meat companies and a biotech company, and it continues to evaluate City-Mix™ with numerous Cellular Agriculture companies across 12 countries. The company plans to establish a web-based sales channel for City-Mix™ in the coming months to aid its direct sales model, catering specifically to the Cultivated Meat market. This channel will provide information, FAQs, and datasheets.

The company has also made progress in building its indirect sales network, securing its first distribution partner, Abacus dx, covering Australia, New Zealand, and Fiji. This is part of a strategy to penetrate the Biotech and Life Sciences markets. Further European distribution partners are planned, expanding 3DBT's geographic reach.

Moreover, 3DBT has entered a confidential contract with a leather company to test and develop lab-grown animal skin for leather production.

The information, investment views, and recommendations in this podcast are provided for general information purposes only. Nothing in this podcast should be construed as a solicitation to buy or sell any financial product relating to any companies under discussion or to engage in or refrain from doing so or engaging in any other transaction. Any opinions or comments are made to the best of the knowledge and belief of the commentator but no responsibility is accepted for actions based on such opinions or comments. The commentators may or may not hold investments in the companies under discussion.